XML 21 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 34,741 $ 32,542
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 1,692 1,850
Non-cash stock-based expense 2,106 2,147
Loss on extinguishment of debt 141 0
Deferred income taxes (62) 3,461
Distributions from investments 0 202
Equity in earnings from investments 159 2,242
Net losses on investment securities 6 3,039
Equity in losses from real estate ventures 1,893 1,877
Distributions from real estate ventures 70 733
Non-cash interest expense 746 1,266
Non-cash lease expense 835 838
Increase (Decrease) in Operating Capital [Abstract]    
Receivables 10,105 (14,209)
Inventories (8,227) (3,376)
Accounts payable and accrued liabilities 141 (9,224)
Payments due under the Master Settlement Agreement 66,911 54,597
Other assets and liabilities, net 9,525 (3,189)
Net cash provided by operating activities 120,782 74,796
Cash flows from investing activities:    
Sale of investment securities 9,455 16,933
Maturities of investment securities 18,459 21,105
Purchase of investment securities (18,389) (27,231)
Purchase of long-term investments 0 (1,000)
Investments in real estate ventures (2,920) (8,488)
Distributions from investments in real estate ventures 0 3,310
Increase in cash surrender value of life insurance policies (272) (765)
Increase in restricted assets (3) 0
Capital expenditures (5,983) (1,222)
Paydowns of investment securities 33 63
Net cash provided by investing activities 380 2,705
Cash flows from financing activities:    
Repurchase and repayments of debt (6,700) (11)
Borrowings under revolving credit facility 87,294 67,298
Repayments on revolving credit facility (109,329) (67,298)
Dividends on common stock (31,680) (31,658)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting and exercise of stock options (3,188) 0
Other 0 (938)
Net cash used in financing activities (63,603) (32,607)
Net increase in cash, cash equivalents and restricted cash 57,559 44,894
Cash, cash equivalents and restricted cash, beginning of period 250,374 194,849
Cash, cash equivalents and restricted cash, end of period $ 307,933 $ 239,743